Infectious Diseases

Most popular

Novel Vaccine Strategy Induces Potent anti-HCV Immune Response

Left: This scanning electron microscope image shows SARS-CoV-2 (round magenta objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S. Source: NIAID-RML. Right: Dr. Gang Chen, MD, PhD, the senior author of a recent case report published in the American Journal of Transplantation that outlined the recovery of an immunosuppressed transplant recipient from COVID-19.

Immunosuppressed Transplant Recipient Recovers from COVID-19

Blood samples resting on a surface.

NantKWest & Be The Match to Advance COVID-19 Therapy BM-AlloMSC

Pills resting on a surface as a reference to the drug remdesivir by Gilead Sciences. The medication is currently being evaluated for the treatment of COVID-19 in phase 3 clinical trials.

Gilead Completes Phase 3 Trial of Remdesivir for Treatment of COVID-19

A person in a laboratory removing a syringe from a container.

Novavax Expands Manufacturing Capacity by Acquiring Praha Vaccines

Angiotensin-converting enzyme inhibitors (ACE inhibitors), which are used to treat certain conditions of the heart and kidneys, are being evaluated in relation to the coronavirus disease 2019 (COVID-19). The image shows a variety of pills and capsules resting on a table.

COVID-19: Considerations regarding the use of ACE inhibitors and ARBs

A nurse wearing a mask holding a syringe containing vaccine.

Inovio’s Vaccine Demonstrates Robust Immunogenicity in Animal Models

Illustration of a pangolin from "On The Genesis of Species" by St. George Mivart.

Coronavirus Source Potentially Traced to Malayan Pangolins

A woman wearing a face mask standing near a building. The COVID-19 vaccine developed by Moderna could lead to the end of the coronavirus pandemic.

Moderna COVID-19 Vaccine: Top 5 Things to Know and Latest Updates

Laboratory test tubes containing a blue liquid resting in a rack.

Vaxart Selects Lead COVID-19 Vaccine Candidate, KindredBio a Partner

1234Page 1 of 4

News

ImmunoFrontiers LLC © 2019-2022. All Rights Reserved. We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites. As an Amazon Associate we earn from qualifying purchases.

SUBSCRIBE
error: Content is protected.